| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.0M | -89.4% |
| R&D Expense | $159.3M | +15.3% |
| SG&A Expense | $44.9M | +3.2% |
| Operating Income | -$158.1M | -162.5% |
| Pre-tax Income | -$129.3M | -146.3% |
| Income Tax | $838K | -80.1% |
| Net Income | -$130.1M | -147.3% |
| EPS (Basic) | -$2.05 | -145.9% |
| EPS (Diluted) | -$2.05 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.4M | +32.0% |
| Short-term Investments | $439.0M | +36.5% |
| Current Assets | $577.6M | -2.4% |
| Total Assets | $668.2M | -10.3% |
| Current Liabilities | $45.4M | -4.1% |
| Total Liabilities | $53.5M | -23.0% |
| Stockholders' Equity | $614.7M | -9.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $57.7M | -68.7% |
| Capital Expenditures | $1.6M | +17.3% |
| Investing Cash Flow | -$49.3M | +83.5% |
| Financing Cash Flow | $22.9M | -11.6% |
| Free Cash Flow | $56.1M | -69.3% |
| -148.5% |